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Introduction
Human exposure to particulate matter (PM) as 
a part of ambient air pollution has a substantial 
impact on human health outcomes such as 
cardiovascular morbidity and mortality and 
respiratory disease (Brunekreef and Holgate 
2002; Nawrot et al. 2011). In 1990, Barker 
hypothesized that adult diseases are already 
programmed by the environment in fetal 
and infant life (Barker 1990). Indeed, recent 
findings suggest that indoor and outdoor 
exposure to environmental PM during in utero 
life is associated with adverse fetal outcomes 
including lower birth weight (Farmer et al. 
2014; Glinianaia et al. 2004; Winckelmans 
et al. 2015). Underlying biological mecha-
nisms involved in PM induced adverse health 
outcomes remain largely unknown, but 
indications of the involvement of inflamma-
tory processes and oxidative stress are rising 
(Farmer et al. 2014; Proietti et al. 2013; Risom 
et al. 2005). PM-induced metabolic alterations 
might provide new insights into underlying 
biological pathways. Lipidomics elucidates 
complex structures and biological function of 
lipids (Shevchenko and Simons 2010), and 
might be important to understand the gene–
environment–health paradigm. Unlike the 
genome, the lipidome (as part of the metabo-
lome) is a very dynamic system that reflects 
the metabolic phenotype of the human body 
(Shevchenko and Simons 2010; Smilowitz 
et al. 2013). As part of the lipidome, oxylipins 
are bioactive lipid compounds originating 
from oxidation of different fatty acid (FA) 
precursors such as the ω-3 FAs (α-linolenic 
acid, docosahexa enoic acid, eicosapentaenoic 
acid) and ω-6 FAs (linoleic acid, arachidonic 
acid) (Zivkovic et al. 2012). Biologically active 
oxylipins are synthesized from these precursors 
primarily through the cyclooxygenase (COX), 
lipoxygenase (5-LOX and 12/15-LOX), and 
cytochrome P450 (CYP) enzymatic pathways. 
Oxylipin alterations have been studied in 
various disease contexts and may play impor-
tant roles in acute and chronic inflammatory 
processes such as asthma, chronic bronchitis, 
chronic obstructive pulmonary disease, cystic 
fibrosis, and atherosclerosis (Conrad 1999; 
Eiserich et al. 2012; Lundström et al. 2011a; 
Tourdot et al. 2014). A growing body of 
knowledge in the field suggests that oxylipins 
may be used as biomarkers of metabolic 
health and disease (Zivkovic et al. 2011), 
and oxylipins may potentially be influenced 
by early life exposures. Both pro- and anti-
inflammatory properties of oxylipins have 
been described, and environmental factors 
affecting these oxylipin levels remain a topic 
of interest (Caligiuri et al. 2014; Dennis and 
Norris 2015). There is limited information 
on the influence of air pollution on oxylipin 
pathways and metabolites, but recent experi-
mental studies using mouse models of athero-
sclerosis suggest that exposure to ultrafine 
particles (UFP) (Li et al. 2013, 2015) and 
diesel exhaust (DE) (Yin et al. 2013) may 
increase levels of linoleic and arachidonic 
acid-derived oxylipins in different tissues and 
plasma. Oxylipin profiles in 18 nonasthmatic 
adults differed between broncho alveolar 
lavage fluid (BALF) samples collected after 
exposure to subway air pollution versus 
ambient air (Lundström et al. 2011b). These 
findings indicate a potential role of oxylipins 
as relevant biomarkers in linking air pollution 
and adverse health outcomes.
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Background: As part of the lipidome, oxylipins are bioactive lipid compounds originating from 
oxidation of different fatty acids. Oxylipins could provide a new target in the developmental origins 
model or the ability of early life exposure to change biology.
oBjectives: We studied the association between in utero PM2.5 (particulate matter with 
aerodynamic diameter < 2.5 μm) exposure and oxylipin profiles in newborns.
Methods: Thirty-seven oxylipins reflecting the cyclooxygenase (COX), lipoxygenase (5-LOX 
and 12/15-LOX), and cytochrome P450 (CYP) pathways were assayed in 197 cord blood plasma 
samples from the ENVIRONAGE birth cohort. Principal component (PC) analysis and multiple 
regression models were used to estimate associations of in utero PM2.5 exposure with oxylipin 
pathways and individual metabolites.
results: A principal component representing the 5-LOX pathway (6 metabolites) was signifi-
cantly positively associated with PM2.5 exposure during the entire (multiple testing–adjusted 
q-value = 0.05) and second trimester of pregnancy (q = 0.05). A principal component representing 
the 12/15-LOX pathway (11 metabolites) was positively associated with PM2.5 exposure during 
the second trimester of pregnancy (q = 0.05). PM2.5 was not significantly associated with the COX 
pathway during any time period. There was a positive but nonsignificant association between 
second-trimester PM2.5 and the CYP pathway (q = 0.16).
conclusion: In utero exposure to particulate matter, particularly during the second trimester, was 
associated with differences in the cord blood levels of metabolites derived from the lipoxygenase 
pathways. These differences may indicate an effect of air pollution during in utero life on the inflam-
matory state of the newborn at birth. Oxylipins may be important mediators between early life 
exposures and health outcomes later in life.
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The exposome encompasses the totality 
of environmental and external exposures, 
including exposure to combustion particles in 
the environment and subsequent physiological 
interaction with the genome, proteome and 
metabolome (Rappaport and Smith 2010; 
Wild 2012). The “pregnancy exposome” is 
important both as the starting point of the 
life-course exposome and because of the 
high vulnerability of the fetus to effects 
of environmental factors. Here, we studied 
associations of cord blood plasma oxylipin 
profiles with in utero exposure to air pollu-
tion (PM2.5; exposure with aerodynamic 
diameter < 2.5 μm) as a potentially important 
component of the pregnancy exposome. We 
measured 37 different oxylipins from the three 
main biosynthetic pathways (COX, LOX, 
and CYP) to study the potential influence of 
in utero PM2.5 exposure on these pathways 
and individual metabolites in the newborn.
Methods
Study Population and Data 
Collection
Thi s  s tudy  i s  pa r t  o f  the  ongo ing 
ENVIRONAGE (ENVIRonmental influ-
ence ON AGEing in early life) birth cohort 
and complies with the Declaration of 
Helsinki and was approved by the Ethics 
Committee of Hasselt University and 
East-Limburg Hospital in Genk, Belgium. 
For the present study, we included 222 
mother–newborn pairs (only singletons) 
from the ENVIRONAGE birth cohort, 
recruited between Friday 1200 hours and 
Monday 0700 hours from February 2010 
through April 2014 from the East-Limburg 
hospital in Genk. Twenty individuals were 
excluded because cord blood plasma samples 
showed hemolysis, 4 were excluded because 
of a lack of exposure data, and 1 was excluded 
because of missing information on maternal 
smoking, resulting in a total study population 
of 197 individuals. The catchment area of 
the hospital included the province Limburg 
in Flanders, Belgium, and combines both 
urban and suburban to rural areas with popu-
lation densities between the municipalities 
ranging from 82 to 743 inhabitants/km2. 
The participation rate of eligible mothers 
in the birth cohort (mothers able to fill out 
a Dutch language questionnaire) was 61% 
and enrollment was spread over all seasons 
of the year. Participating mothers provided 
written informed consent when they arrived 
at the hospital for delivery. They completed 
study questionnaires in the postdelivery 
ward to provide detailed information on 
maternal age, pregestational body mass 
index (BMI), maternal education, occupa-
tion, smoking status, alcohol consump-
tion, place of residence, use of medication, 
parity, and the newborn’s ethnicity. Former 
smokers were defined as those who had quit 
smoking before pregnancy. Smokers were 
those who continued smoking during preg-
nancy. Based on the native country of the 
newborn’s grandparents, we classified his/
her ethnicity as European-Caucasian when 
two or more grandparents were European or 
non-European when at least three grandpar-
ents were of non-European origin. Maternal 
education was coded as “low” (no diploma 
or primary school), “middle” (high school), 
or “high” (college or university degree). The 
ENVIRONAGE birth cohort did not differ 
from all births in Flanders, Belgium, as to 
maternal age, education, gender, ethnicity, 
and birth weight (see Table S1) (Cox et al. 
2013); but compared with all births in 
Flanders, our population was more likely to 
be primiparous (56% vs. 47%) and less likely 
to have had three or more previous births 
(10% vs. 18%). Cord blood samples were 
collected immediately after delivery, along 
with perinatal parameters such as birth 
date, gestational age, the newborn’s gender, 
birth weight, and length, Apgar score, pH 
of arterial cord blood, and ultrasonographic 
data. Immediately after birth, all neonates 
were assessed for congenital anomalies and 
were considered healthy when the Apgar score 
after 5 min ranged between 7 and 10.
Exposure Assessment
Regional background levels of PM2.5 
(μg/m3) were interpolated for each mother’s 
residential address separately using a spatial 
temporal interpolation method (kriging) 
(Janssen et al. 2008). This method uses pollu-
tion data collected in the official fixed-site 
monitoring networks (n = 34) and land 
cover data obtained from satellite images 
(CORINE land cover data set; http://www.
eea.europa.eu/publications/COR0-landcover) 
in combination with a dispersion model as 
described by Lefebvre et al. (2011, 2013). 
This model chain provides daily PM2.5 values 
using data both from the Belgian telemetric 
air quality network, point sources, and line 
sources which then are interpolated to a 
 high- resolution receptor grid (25 × 25 m). 
The interpolation tool explained > 80% of 
the temporal and spatial variability (R2) in 
the Flemish region of Belgium (Maiheu et al. 
2013). Total PM2.5 exposure for entire preg-
nancy duration was calculated as the mean 
PM2.5 concentration (μg/m3) of all pregnancy 
days. Date of conception was estimated 
based on ultrasonographic data (Janssen 
et al. 2012). Additionally, we calculated 
mean PM2.5 (μg/m3) concentrations during 
each trimester of pregnancy (1–13 weeks, 
14–26 weeks, and 27 weeks until delivery). 
Address changes for 24 mothers (12%) 
who moved residence during pregnancy 
were taken into account when calculating 
 exposures during the different time windows.
Sample Collection and Oxylipin 
Profiling by UPLC-ESI-MS/MS
Umbilical cord blood (mixture of arterial and 
venous blood) was collected directly after 
delivery in BD Vacutainer® plastic whole 
blood tubes with spray-coated K2EDTA 
(BD, Franklin Lakes, NJ, USA). Within 
20 min after cord blood collection, samples 
were centrifuged at 3,200 rpm for 15 min 
to separate plasma from blood. Plasma was 
collected and stored in Eppendorf® tubes at 
–80°C until analysis. Cord blood plasma levels 
of total cholesterol and high-density lipo-
protein (HDL) was measured using a Roche 
cobas c701 system (F. Hoffmann-La Roche 
AG, Basel, Switzerland). Oxylipin analysis was 
performed as previously described and vali-
dated (Gouveia-Figueira et al. 2015). Native, 
deuterated internal standards (IS) and the 
recovery standard CUDA (12-{[(cyclohex-
ylamino) carbonyl]amino}-dodecanoic acid) 
were purchased from Cayman Chemical (Ann 
Arbor, MI, USA) or Larodan Fine Chemicals 
AB (Malmö, Sweden) (see “Chemical details 
for UPLC-MS/MS” in the Supplemental 
Material for details). All solvents were of 
HPLC grade or higher. A Milli-Q Gradient 
system (Millipore, Milford, MA, USA) was 
used to purify water used in UPLC mobile 
phase. In brief, oxylipins were extracted 
using a solid phase extraction (SPE) proce-
dure on 60 mg Waters Oasis-HLB cartridges 
(Milford, MA, USA). Cartridges were washed 
and then preconditioned with MilliQ water 
buffer (5% methanol, 0.1% acetic acid). 
Next, 750 μL of cord plasma together with 
10 μL antioxidant solution [0.2 mg/mL butyl-
hydroxy toluene, EDTA in methanol/water 
(1:1)] and 10 μL of internal standard mixture 
(400 nM/standard, 12,13-DiHOME-d4, 
9-HODE-d4, PGE2-d4, TXB2-d4) solution 
were applied on the cartridge. Cartridges were 
rinsed with 2 × 2 mL buffer and oxylipins 
were then eluted using 2 mL methanol and 
2 mL ethyl acetate in tubes containing 6 μL 
30% glycerol solution in methanol. Next, 
solvents were evaporated using a SpeedVAC 
system (Farmingdale, NY, USA). Residues 
were reconstituted in 100 μL methanol and 
the solution was transferred into LC-vials 
containing 10 μL recovery standard solution 
(5 ng/mL CUDA).
Profiling of oxylipins was performed 
by injecting 10 μL of the solution in the 
LC-vial on an Agilent 6490 triple quadrupole 
UPLC-MS/MS system equipped with the 
iFunnel Technology (Agilent Technologies, 
Santa Clara, CA, USA) operating in negative 
mode. An Acquity UPLC BEH C18 column 
(Waters) with in-line filter (2.1 × 150 mm, 
130 Å, 1.7 μm particle size) was used at 
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40°C for chromatographic separation using a 
constant flow rate of 0.3 mL/min. The mobile 
phase consisted of a) 0.1% acetic acid in 
MilliQ water and b) acetonitrile:isopopanol 
(90:10) with the following gradient for 
acetonitrile:isopopanol (90:10): 0.0–3.5 min 
10–35%, 3.5–5.5 min 40%, 5.5–7.0 min 
42%, 7.0–9.0 min 50%, 9.0–15.0 min 
65%, 15.0–17.0 min 75%, 17.0–18.5 min 
85%, 18.5–19.5 min 95%, 19.5–21 min 
10%, 21.0–25.0 min 10%. Peak identifica-
tion and manual integration was performed 
using the MassHunter Workstation Software 
(Agilent Technologies). The stable isotope 
dilution method was used to quantify each 
metabolite using calibration curves of ratios 
of peak areas of native compounds by IS 
peak area (see Tables S2 and S3 for IS 
assignment to each native standard and cali-
bration curves concentrations respectively). 
The recovery rates (%, mean ± SD, n) of 
the internal standards in the present study 
were as follows: TXB2-d4 (68 ± 18, n = 97), 
12(13)-DiHOME-d4 (90 ± 13, n = 197), 
9(S)-HODE-d4 (76 ± 19, n = 197), and 
PGE2-d4 (85 ± 23, n = 197). Samples with 
analyte peak areas below the limit of detec-
tion (LOD) were assigned a value of LOD/2 
[LOD values were previously reported and 
are provided in Table S4 (Gouveia-Figueira 
et al. 2015)].
Statistical Analysis
For database management and statistical 
analysis, we used SAS 9.3 software (SAS 
Institute Inc., Cary, NC, USA). Metabolite 
concentrations were log10 transformed to 
approximate the normal distribution. For 
logarithmically transformed variables, we 
report central tendency and spread of data 
as geometric mean and interquartile range, 
respectively. Based on different pathways 
involved in oxylipin biosynthesis, metabo-
lites were classified by the main biosynthetic 
pathways COX, CYP, 5-LOX, and 12/15-
LOX (Figure 1; see also Table S4) (Zivkovic 
et al. 2012). We combined metabolites origi-
nating from the same pathway into different 
principal components using the PROC 
PINCOMP procedure in SAS 9.3. We 
derived unadjusted Pearson correlations for 
the first principal component of each pathway 
and PM2.5 during each time window. In our 
main analyses, we used separate multi-variable 
adjusted principal component regressions 
to estimate associations between in utero 
PM2.5 exposures and the oxylipin pathways, 
using the first principal components as the 
dependent variables in these models. The 
multi-variable–adjusted models were adjusted 
for gestational age, pregestational BMI, 
and maternal age as continuous variables; 
maternal smoking status (never, ex-smoker, 
current), maternal education (low, middle, 
high); newborn gender; cord blood total 
cholesterol and HDL concentrations (contin-
uous); batch; and sample storage time. Due 
to correlations between different exposure 
windows (trimesters of pregnancy) of PM2.5, 
models of trimester-specific associations were 
additionally adjusted for PM2.5 exposure 
during the other trimesters. We applied 
the Benjamini–Hochberg false discovery 
rate (FDR) correction for multiple testing 
(represented by a q-value) based on the four 
different pathways and four different exposure 
windows tested (total number of tests = 16). 
Pathway models were classified as signifi-
cant when q-values where ≤ 0.05. Individual 
metabolites from significantly associated 
pathways revealed in the main analysis by 
principal component regression were tested 
in a secondary analysis for PM2.5 dependency 
during the different significant exposure 
windows using multiple linear regression 
models. Estimates (beta-coefficients) of the 
principal component regression models and 
Figure 1. Metabolic scheme of targeted oxylipins. Oxylipin synthesis via different biosynthetic pathways, COX, 5-LOX, 12/15-LOX, and CYP from their corre-
sponding precursor fatty acids, arachidonic acid, eicosapentaenoic acid, dihomo-γ-linolenic acid, and linoleic acid (Zivkovic et al. 2012). All shown metabolites 
were targeted except for 5-HPETE (5-hydroperoxy-eicosatetraenoic acid), LTA4 (Leukotriene A4), and PGH2 (prostaglandin H2) and classified by biosynthetic 
pathway. Nondetectable targeted oxylipins (17-HDoDE, Resolvin D1, and Resolvin D2) are not shown on the scheme. A list of full metabolite names is provided 
in Table S4.
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percent change in individual metabolite 
concentration (nM) are presented for each 
5 μg/m3 increase of PM2.5. Q-Q plots of the 
residuals showed a normal distribution (data 
not shown).
Sensitivity Analyses
We performed the following sensitivity 
analyses for pathways with significant associa-
tions with PM2.5 during at least one exposure 
time window: models additionally adjusted 
for third-trimester apparent temperature 
(based on tertiles of third-trimester apparent 
temperature to account for potential non-
linearity); models additionally adjusted for 
trimester-specific average NO2 concentra-
tions; models that included PM2.5 concentra-
tions during only one trimester; models that 
excluded women with a cesarean (C-) section 
or one of the following pregnancy compli-
cations: diabetes, hypertension, hypo- and 
hyperthyroidism, and mothers with an infec-
tion during pregnancy (n = 18); models 
that were not adjusted for gestational age; 
and models stratified by newborn gender. In 
addition, for each significant pathway, we 
modeled principal components that were 
derived after excluding unstable metabolites 
(defined as metabolites that were significantly 
associated with storage time) and metabolites 
with > 40% of sample concentrations < LOD.
Results
Characteristics of the Study 
Population and Exposure Levels
General characteristics of the study popula-
tion consisting of 197 mother–newborn pairs 
are presented in Table 1. Data presented 
are complete for all variables other than 
cord blood pH (n = 177). Average maternal 
age was 29.1 years and ranged from 19 to 
44 years. Mothers had an average (± SD) 
pregestational BMI of 23.8 ± 4.7 kg/m2. Most 
women (70%, n = 137) never smoke ciga-
rettes, and 44 women (22%) stopped smoking 
before pregnancy, whereas 16 mothers (8%) 
continued smoking during pregnancy. 
About 85% (n = 168) of the newborns 
were Europeans of Caucasian ethnicity. 
Five minutes after delivery, > 90% of the 
newborns had an Apgar score of 9 or 10. The 
newborns, among them 89 girls (45.2%) and 
108 boys (54.8%), had a mean gestational 
age of 39.3 weeks (range, 33–41 weeks) and 
comprised 111 (56%) primiparous and 66 
(34%) secundiparous newborns. Birth 
weight averaged 3,453 ± 420 g, ranging from 
2,135 to 4,445 g. Among the newborns, 10 
(5.1%) were preterm births (gestational age 
< 37 weeks) and 3 (1.5%) had a low birth 
weight (< 2,500 g). Mean cord blood plasma 
total cholesterol and HDL levels were, respec-
tively, 69 ± 18 mg/dL and 31 ± 11 mg/dL. 
Among the mothers, 11 (5.6%) were diag-
nosed with gestational diabetes, 3 (1.5%) had 
hypertension, 1 mother (0.5%) had hypo-
thyroidism, and 3 (1.5%) had an infection 
during pregnancy. In total 7 mothers (3.6%) 
had a C-section. Of the 18 mothers who expe-
rienced a pregnancy complications, 2 had a 
C-section. Cord blood plasma oxylipins were 
analyzed in three batches within 3 consecutive 
days and the average storage time for cord 
blood plasma samples was 84.6 ranging from 
7.3 to 218.7 weeks. Table 2 displays the daily 
outdoor PM2.5 exposure levels averaged for 
each of the three trimesters of pregnancy. 
Average PM2.5 concentrations for the first, 
second, and third trimester of pregnancy were 
15.5 ± 5.4 μg/m3, 15.4 ± 5.1 μg/m3, and 
16.1 ± 5.2 μg/m3 respectively. During entire 
pregnancy, PM2.5 exposure concentrations 
averaged 15.7 ± 2.6 μg/m3. First- and third-
trimester PM2.5 concentrations were inversely 
correlated (r = –0.57, p < 0.0001), whereas 
first- and third-trimester PM2.5 concentra-
tions did not correlate with second-trimester 
PM2.5 concentrations (r = 0.09, p = 0.22 and 
r = 0.08, p = 0.26, respectively).
Oxylipin Levels in Newborns
We targeted 37 different individual oxylipins 
in cord blood plasma and detected 34 of 
them. Resolvin D1, Resolvin D2, and 
17-HDoHE were not detected above the 
LOD in any of the samples, so we excluded 
these metabolites from further statistical 
analysis. Mean cord blood plasma oxylipin 
concentrations (nM) are shown in Table S4. 
For 21 metabolites all samples were detected 
above the LOD, and for another 10 metab-
olites ≥ 94% of the samples were detected 
above the LOD (see Table S4). LTB4 
was detected in only 28% of the samples, 
12-oxoETE was detected in only 56% of the 
samples, and 9-HETE was detected in 77% 
of the samples. Three metabolites (9,10,13-
TriHOME, 9,12,13-TriHOME, and TXB2) 
showed a significant negative association with 
storage time and were classified as unstable 
(data not shown).
Cord Blood Oxylipin Pathways in 
Association with Maternal PM2.5 
Exposure
A heat map illustrating the correlations 
between the individual metabolites in each 
of the four studied oxylipin pathways is 
provided in Figure S1. For each oxylipin 
biosynthetic pathway (COX, CYP, 5-LOX, 
12/15-LOX; see Figure 1 and also Table S4 
for assignment), principal components were 
derived as linear combinations of different 
metabolites involved in each pathway. The 
first principal components explained 42–55% 
of the variance for the four individual 
pathways, and factor loadings were ≥ 0.54 
for 28 of the 34 individual metabolites (see 
Table S5). Characteristics of the first principal 
Table 1. Characteristics of mother–newborn pairs 
(n = 197) selected from the ENVIRONAGE birth 
cohort between February 2010 and April 2014.
Characteristic
Mean ± SD  
or n (%)
Maternal
Age (years) 29.1 ± 4.8
Education 
Low 27 (13.7)
Middle 76 (38.6)
High 94 (47.7)
Smoking status 
Never-smoker 137 (69.5)
Stopped smoking before pregnancy 44 (22.4)
Continued smoking during pregnancy 16 (8.1)
Alcohol consumption during pregnancy
No 167 (84.8)
Pregestational BMI (kg/m2) 23.8 ± 4.7
Parity
1 111 (56.4)
2 66 (33.5)
≥ 3 20 (10.1)
Cesarean section 7 (3.6)
Pregnancy complications
Gestational diabetes 11 (5.6)
Hypertension 3 (1.5)
Hypo-/hyperthyroidism 1 (0.5)
Infection 3 (1.5)
Newborn
Gender
Boys 108 (54.8)
Ethnicity 
European-Caucasian 168 (85.3)
Gestational age (weeks) 39.3 ± 1.4
Apgar score 5 min after birth
7 3 (1.5)
8 15 (7.6)
9 61 (31.0)
10 118 (59.9)
Season of delivery
Winter 59 (30)
Spring 37 (19)
Summer 52 (26)
Autumn 49 (25)
pH artery cord blood 7.3 ± 0.07
Birth weight (g) 3453.6 ± 420.7
Total cholesterol (mg/dL) 69.0 ± 18.0
HDL level (mg/dL) 30.6 ± 10.8
Complete data for all variables except for pH artery cord 
blood (n = 177).
Table 2. Outdoor PM2.5 (μg/m3) exposure characteristics for the 197 mothers included in this study from 
the ENVIRONAGE birth cohort.
Exposure window Mean ± SD 25th percentile 75th percentile
Trimester 1 15.5 ± 5.4 11.4 19.9
Trimester 2 15.4 ± 5.1 11.1 19.7
Trimester 3 16.1 ± 5.2 12.0 19.8
Entire pregnancy 15.7 ± 2.6 13.5 17.5
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components used in the multi-variable–
adjusted principal component regression 
models are shown in Table S5. Both before 
(Figure 2) and after adjustment for gesta-
tional age, pregestational BMI, maternal age, 
maternal smoking status, maternal education, 
newborn gender, cord blood total cholesterol 
and HDL levels, batch and storage time in 
multi-variable–adjusted models, the 5-LOX 
and 12/15-LOX oxylipin pathways were posi-
tively and significantly (q ≤ 0.05) associated 
with in utero exposure to PM2.5 during the 
second trimester of pregnancy (Figure 3). The 
5-LOX pathway also was positively associ-
ated with PM2.5 exposure during the entire 
pregnancy (q = 0.05), whereas the association 
with the 12/15-LOX pathway was positive 
but not significant (q = 0.19). Positive but 
nonsignificant associations were also esti-
mated for the principal component reflecting 
the CYP pathway and PM2.5 exposure during 
the second trimester (q = 0.16) and the 
entire pregnancy (q = 0.5) (Figure 3). The 
principal component reflecting the COX 
pathway was not significantly associated with 
PM2.5 exposure during any time period. 
Results of the sensitivity analyses for 5-LOX 
and exposure during the second trimester 
and entire pregnancy, and for 12/15-LOX 
and exposure during the second trimester, 
were generally consistent with the main 
analyses (Table 3).
Individual Cord Blood Oxylipins 
Associated with Maternal PM2.5 
Exposure
Associations between all metabolites (inde-
pendent of pathways) with exposure during 
all different pregnancy time windows are 
summarized in Figure S2 and Table S6. After 
identification of aforementioned signifi-
cantly associated oxylipin pathways with 
in utero exposure to PM2.5 during the second 
trimester and entire pregnancy, we further 
examined individual metabolites of the 
5-LOX and 12/15-LOX pathways in associa-
tion with these significant exposure windows 
(Table 4). Positive associations of 3 profiled 
5-LOX metabolites [5-HETE, p = 0.03; 
5-oxoETE, p = 0.03; 9(S)-HODE, p = 0.06] 
were estimated in relation with in utero 
PM2.5 exposure during second trimester. 
Exposure during the entire pregnancy was 
positively associated with the following 
5-LOX metabolites: 5-HETE, p = 0.05; 
5-oxoETE, p = 0.006; 9,10,13-TriHOME, 
p = 0.08; and 9,12,13-TriHOME, p = 0.05. 
Eight of the 11 targeted individual linoleic 
(13-HODE, p = 0.05), arachidonic acid 
(8-HETE, p = 0.02; 11-HETE, p = 0.02; 
12-HETE, p = 0.02; 12-oxoETE, p = 0.03 
and 15-HETE, p = 0.006), eicosapen-
taenoic acid [12(S)-HEPE, p = 0.02], and 
dihomo-γ-linolenic [15(S)-HETrE, p = 0.04] 
Figure 2. Unadjusted Pearson correlation plots with 95% confidence intervals between oxylipin pathways 
and PM2.5 exposure during the second trimester: (A) correlation with the 5-LOX pathway and (B) correla-
tion with the 12/15-LOX pathway. PC1, first principal component. 
Figure 3. Association between oxylipin biosynthetic pathways and in utero PM2.5 exposure during different 
time windows. Estimates are presented for each 5-μg/m3 increase in PM2.5. Models were adjusted for 
gestational age, pregestational BMI, maternal age, maternal smoking status, maternal education, newborn 
gender, cord blood total cholesterol and HDL levels, batch, and sample storage time. Trimester-specific 
windows were additionally adjusted for the other PM2.5 exposure windows (trimesters). Q indicates the 
multiple testing adjusted p-values using the Benjamini–Hochberg procedure.
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derived metabolites from the 12/15-LOX 
pathway were positively associated with 
in utero exposure to PM2.5 during the second 
trimester of pregnancy.
Discussion
The key finding of our paper is that in utero 
exposure to PM2.5 during pregnancy is associ-
ated with levels of free circulating oxylipins 
in cord blood plasma, particularly oxylipins 
from the lipoxygenase pathway (5-LOX 
and 12/15-LOX). Several individual cord 
blood oxylipins included in the 5-LOX and 
12/15-LOX pathways were associated with 
in utero exposure to PM2.5 during the second 
trimester. To our knowledge, this is the first 
extensive report on targeting 37 oxylipins in 
cord blood simultaneously by LC/MS-MS 
quantification. These findings elucidate 
new early-life effects of air pollution on the 
metabolomic level, more specifically at the 
level of oxylipins.
To date, evidence concerning PM-induced 
alterations of circulating oxylipin metabolites 
is limited to experimental findings in mice. 
Apolipoprotein E–deficient mice exposed to 
diesel exhaust for 2 weeks showed increased 
concentrations of oxylipins (5-HETE, 
12-HETE, 15-HETE, and 13-HODE) 
targeted from the 5-LOX and 12/15-LOX 
pathway compared with FA-exposed mice. 
Plasma levels of 12-HETE and 13-HODE 
were significantly elevated in exposed mice 
compared with the FA controls, and in liver 
and large intestine tissue only 5-HETE showed 
increased concentrations in the exposed 
mice. In BALF samples, both higher levels of 
12-HETE and 15-HETE were measured in 
the DE-exposed mice compared with the FA 
controls, showing different elevated oxylipins 
in different tissues (Yin et al. 2013). In 2013 
Li et al. (2013) reported that plasma levels of 
9-HODE and 12-HETE were significantly 
higher in LDLR-null mice exposed to UFP 
compared with mice exposed to FA. Findings 
for plasma 13-HODE and 5-HETE were 
inconclusive, but mean concentrations were 
higher in mice exposed to UFP versus FA 
(p = 0.16 and 0.19 respectively). In a second 
study of UFP exposed LDLR-null mice by 
Li et al. (2015), significantly higher levels of 
5-HETE, 12-HETE, 15-HETE, 9-HODE, 
13-HODE, and PGD2 were reported in 
intestine and liver tissue of UFP-exposed mice 
compared with FA-exposed mice. In plasma, 
only 12-HETE, 15-HETE, and PGD2 levels 
were significantly higher when comparing 
Table 3. Sensitivity analyses for the 5-LOX and 12/15-LOX pathways in association with in utero PM2.5 exposure.
Analysis
Trimester 1 PM2.5 Trimester 2 PM2.5 Trimester 3 PM2.5 Entire pregnancy PM2.5
β (95% CI) p-Value β (95% CI) p-Value β (95% CI) p-Value β (95% CI) p-Value
5-LOX
Main model 0.05 (–0.25, 0.35) 0.73 0.29 (0.07, 0.52) 0.01 0.13 (–0.18, 0.45) 0.41 0.64 (0.16, 1.12) 0.01
Apparent temperature adjusted 0.02 (–0.40, 0.44) 0.93 0.28 (0.01, 0.55) 0.04 0.12 (–0.26, 0.50) 0.53 0.67 (0.14, 1.19) 0.01
NO2 adjusted –0.12 (–0.62, 0.37) 0.62 0.32 (–0.02, 0.67) 0.06 0.30 (–0.12, 0.72) 0.16 0.70 (0.06, 1.33) 0.03
Single-trimester PM2.5 –0.01 (–0.23, 0.21) 0.94 0.30 (0.08, 0.52) 0.008 0.11 (–0.12, 0.34) 0.35 NA NA
Boys (n = 108) –0.06 (–0.47, 0.35) 0.78 0.34 (0.03, 0.65) 0.03 0.12 (–0.29, 0.53) 0.57 0.65 (0.00, 1.30) 0.05
Girls (n = 89) 0.38 (–0.18, 0.93) 0.18 0.31 (–0.06, 0.68) 0.10 0.31 (–0.25, 0.88) 0.28 0.98 (0.21, 1.75) 0.01
Not adjusted for gestational age 0.06 (–0.24, 0.35) 0.71 0.29 (0.07, 0.51) 0.01 0.14 (–0.17, 0.44) 0.38 0.63 (0.16, 1.11) 0.009
Excluding pregnancy complications 
and C-sections (n = 174)
0.09 (–0.23, 0.41) 0.58 0.27 (0.04, 0.50) 0.02 0.18 (–0.14, 0.51) 0.27 0.66 (0.17, 1.15) 0.009
Excluding TriHOMEs and LTB4a 0.04 (–0.24, 0.31) 0.80 0.26 (0.06, 0.47) 0.01 0.03 (–0.26, 0.31) 0.86 0.52 (0.08, 0.95) 0.02
12/15-LOX
Main model –0.14 (–0.60, 0.32) 0.55 0.50 (0.15, 0.84) 0.005 –0.23 (–0.71, 0.24) 0.34 0.70 (–0.04, 1.44) 0.06
Apparent temperature adjusted –0.34 (–0.98, 0.30) 0.30 0.38 (–0.03, 0.78) 0.07 –0.03 (–0.60, 0.55) 0.92 0.64 (–0.16, 1.44) 0.12
NO2 adjusted –0.44 (–1.19, 0.31) 0.25 0.56 (0.04, 1.08) 0.03 –0.19 (–0.83, 0.46) 0.57 0.83 (–0.15, 1.82) 0.10
Single-trimester PM2.5 0.05 (–0.29, 0.39) 0.77 0.47 (0.13, 0.81) 0.007 –0.11 (–0.46, 0.25) 0.56 NA NA
Boys (n = 108) –0.24 (–0.91, 0.42) 0.47 0.56 (0.06, 1.06) 0.03 –0.08 (–0.76, 0.59) 0.81 0.78 (–0.27, 1.84) 0.14
Girls (n = 89) –0.03 (–0.79, 0.73) 0.93 0.52 (0.01, 1.03) 0.04 –0.40 (–1.17, 0.37) 0.31 0.91 (–0.18, 1.99) 0.10
Not adjusted for gestational age –0.08 (–0.54, 0.37) 0.72 0.48 (0.13, 0.82) 0.007 –0.17 (–0.65, 0.30) 0.47 0.73 (0.00, 1.47) 0.05
Excluding pregnancy complications 
and C-sections (n = 174)
–0.08 (–0.59, 0.42) 0.74 0.46 (0.10, 0.82) 0.01 –0.12 (–0.62, 0.39) 0.65 0.74 (–0.02, 1.51) 0.06
Excluding 12-oxoETEb –0.14 (–0.59, 0.32) 0.56 0.48 (0.14, 0.82) 0.007 –0.23 (–0.71, 0.24) 0.34 0.67 (–0.07, 1.40) 0.08
Beta-coefficients are presented for each 5-μg/m3 increase in PM2.5. Unless otherwise indicated, all models were adjusted for gestational age, pregestational BMI, maternal age, 
maternal smoking status, maternal education, newborn gender, cord blood total cholesterol and HDL levels, batch, and sample storage time. 
aExclusion of unstable 9,10,13-TriHOME and 9,12,13-TriHOME due to storage time dependency and LTB4 due to 72% of the samples under the limit of detection (LOD). 
bExclusion of 12-oxoETE because 44% of the samples were below the LOD.
Table 4. Estimated percent difference in individual metabolite concentration (nM) from the 5-LOX and 
12/15-LOX pathways in association with in utero PM2.5 exposure.
Pathway/metabolite
Loading on 
first PC
Trimester 2 PM2.5 Entire pregnancy PM2.5
% difference (95% CI)a,b,c p-Value % difference (95% CI)a,b p-Value
5-LOX
5-HETE 0.62 11.7 (1.4, 23.1) 0.03 22.5 (–0.4, 50.7) 0.05
5-oxoETE 0.61 20.3 (1.7, 42.4) 0.03 66.0 (16.2, 137.3) 0.006
9(S)-HODE 0.76 11.9 (–0.3, 25.6) 0.06 17.2 (–8.4, 50.0) 0.20
LTB4 0.05 –1.8 (–13.2, 11.0) 0.77 3.0 (–20.9, 34.2) 0.82
9,10,13-TriHOME 0.76 8.5 (–3.2, 21.5) 0.16 24.6 (–2.2, 58.9) 0.08
9,12,13-TriHOME 0.81 9.5 (–1.7, 21.9) 0.10 25.6 (–0.2, 58.0) 0.05
12/15-LOX
8-HETE 0.83 15.3 (2.4, 29.8) 0.02 NA NA
9-HETE 0.31 16.1 (–8.8, 47.7) 0.22 NA NA
11-HETE 0.93 14.0 (2.3, 27.1) 0.02 NA NA
12-HETE 0.83 28.7 (4.7, 58.2) 0.02 NA NA
12(S)-HEPE 0.63 27.9 (4.7, 56.2) 0.02 NA NA
12-oxoETE 0.55 49.7 (3.2, 117.1) 0.03 NA NA
15-HETE 0.90 16.3 (4.5, 29.4) 0.006 NA NA
15(S)-HETrE 0.88 15.7 (0.8, 32.7) 0.04 NA NA
15-oxoETE 0.64 10.3 (–3.9, 26.7) 0.16 NA NA
13-HODE 0.81 11.4 (–0.2, 24.3) 0.05 NA NA
13-oxoODE 0.59 8.0 (–5.8, 23.8) 0.27 NA NA
first PC, first principal component.
aEffect size was estimated for an increase of 5 μg/m3 of PM2.5. 
bModels adjusted for gestational age, pregestational BMI, maternal age, maternal smoking status, maternal education, 
newborn gender, cord blood total cholesterol and HDL levels, batch and sample storage time. 
cAdditional adjustment for the other PM2.5 exposure windows (trimesters). NA as the 12/15-LOX pathway is not signifi-
cant for this exposure window. 
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UFP-exposed with FA-exposed mice. 
Reported higher plasma levels of 5-HETE, 
9-HODE, and 13-HODE in UFP-exposed 
mice compared with FA-exposed mice were 
inconclusive (Li et al. 2015). These findings 
in animal studies are in line with our reported 
associations of in utero PM2.5 exposure with 
oxylipin profiles of the 5-LOX and 12/15-LOX 
pathway. Exposure during the second trimester 
was associated with cord blood plasma levels of 
5-HETE, 12-HETE, 15-HETE, 9-HODE, 
and 13-HODE. However, the COX-derived 
PGD2 metabolite was not significantly asso-
ciated with PM2.5 exposure during any time 
period in our study population (see Figure S2 
and Table S6). Findings from the experimental 
studies, which used mouse models of athero-
sclerosis and high diesel exhaust and UFP expo-
sures [e.g., 360 ± 25 μg/m3 of UFP in Li et al. 
(2015) compared with mean PM2.5 concentra-
tions of 15.7 ± 2.6 μg/m3 in our study popula-
tion], cannot be directly compared with the 
findings from our observational birth cohort 
study. Nonetheless, the experimental findings 
are generally consistent and support our results. 
Our findings, supported by these animal-based 
studies, suggests an important role of PM 
exposure in the alteration of the 5-LOX and 
12/15-LOX pathways and derived oxylipins. 
Our findings indicate possible early 
immunological alterations due to early-life 
exposure to particulate air pollution. Indeed, 
B-lymphocytes are able to produce the major 
5-LOX metabolites 5-HETE and LTB4 in 
the presence of exogenous arachidonic acid 
and oxidative stress (Jakobsson et al. 1995). 
Grant et al. (2011) showed that the more 
biological active 5-oxoETE was produced 
in human B lymphocyte cell lines from its 
precursor 5-HETE after subjection to oxida-
tive stress by H2O2. These findings suggest 
the ability of PM to induce oxidative stress 
by producing reactive oxygen species (ROS), 
which might stimulate the production of 
5-HETE and 5-oxoETE in different types 
of leukocytes, reflecting a higher inflamma-
tory state. However, the exact sources of the 
oxylipin metabolites measured in cord blood 
for our study are unknown. 
M e t a b o l i t e s  o f  t h e  1 2 / 1 5 - L O X 
pathway have been indicated in pro- and 
 anti- inflammatory responses (Uderhardt and 
Krönke 2012). Anti-inflammatory effects 
of 15-HETE and 13-HODE are related to 
their ability to modulate the activity of the 
peroxisome proliferator-activated receptor γ 
(PPARγ), implicated in adipocyte differen-
tiation regulation, fatty acid storage, glucose 
metabolism, and anti-inflammatory processes 
(Martin 2010). In contrast to the involvement 
in anti-inflammatory properties, 15-HETE has 
been described in pro-inflammatory responses 
involved in air-way inflammatory diseases and 
asthma (Conrad 1999; Larsson et al. 2014; 
Lundström et al. 2011b; Sachs-Olsen et al. 
2010). Our findings suggest that the second 
trimester of pregnancy is a very susceptible 
period for exposure in altering oxylipins. A 
potential explanation for this observation could 
be the fact that during pregnancy the syncytio-
throphoblast layer, which forms the barrier 
between maternal and fetal blood, gets thinner 
with gestational age, and until week 10 of 
pregnancy the size of fetal capillaries increases 
leading to enhanced maternal fetal exchange 
of nutrients and particles (Proietti et al. 2013; 
Wick et al. 2010).
Strong points of our study are the 
high-resolution exposure estimates and 
integration of daily exposures to estimate 
pregnancy-specific exposure windows. The 
epidemiologic angle from the early-life perspec-
tive enhances the relevance of our findings for 
public health beyond that of studies in patients 
or older population segments that might be 
confounded by multiple comorbidities and 
polymedication. However, our present study 
must also be interpreted within the context of 
its limitations. Metabolomics is a top-down 
systems biology approach to understand the 
gene–environment–health paradigm. Cord 
blood is an important matrix to study metabo-
lomic changes in the context of perinatal 
programming. However, we are able to study 
the associations only on changes in profiles at 
birth and not during pregnancy, which might 
be a limitation. Our sample size was relatively 
small, which might reduce the generalizability. 
Next, we analyzed oxylipin metabolites only in 
cord blood and not in maternal plasma during 
pregnancy, having only one snapshot at birth 
with no insight into the maternal link to the 
fetal oxylipin profiles. Keeping in mind the 
redundancy and bidirectionality in many meta-
bolic pathways, studies such as ours cannot 
determine whether a metabolite is increased 
because of increased production, decreased 
degradation and/or uptake, or both. We also 
need to address the importance of maternal 
nutrition on the oxylipin state of the newborn, 
which may be an important factor influencing 
oxylipin levels that could not be taken into 
account in the present study. Essential fatty 
acids such as the ω-3 FA α-linolenic acid 
and ω-6 FA linoleic acid, which are precur-
sors for oxylipin synthesis, have to be provided 
to the fetus by maternal nutrition (Herrera 
2002). Because there exists a linear correla-
tion between maternal intake of dietary 
fatty acids and maternal plasma and cord 
blood plasma concentrations of fatty acids, 
these might influence newborns’ oxylipin 
levels (Donahue et al. 2011; Herrera 2002). 
However, we do not expect exposure to air 
pollution to be associated with omega-fatty 
acid consumption in our study population, 
so it is unlikely that these nutritional aspects 
have confounded our reported associations. 
However, we cannot completely rule out 
unmeasured factors including nutrition that 
correlate with air pollution or its variation over 
seasons. Although we have used a standardized 
fine-scale exposure model for the estimation 
of residential fine particulate matter, maternal 
daily activity patterns could not be taken into 
account which contribute to maternal exposure 
levels. Furthermore, PM2.5 might present an 
epiphenomena or a proxy for exposure to other 
air pollutants. However, the observation that 
only PM2.5 was statistically significant in two-
pollutant models (including both nitrogen 
dioxide and PM2.5) highlights the indepen-
dent role of particles. However, we did not 
address to what extent specific constituents of 
the particulate matter were responsible for the 
observed associations. Finally, epidemiologic 
studies demonstrate association, and the inter-
pretation of the association with the metabolic 
marker rests on review and interpretation of 
the literature, which involves some degree of 
speculation. Nevertheless, our observational 
findings in mother–newborn pairs add to 
existing knowledge in the field of effects of air 
pollution exposure on oxylipin levels.
Conclusions
To our knowledge, our study is the first to 
report positive associations of metabolites 
from the 5-LOX and 12/15-LOX pathways 
in newborns with in utero exposure to 
PM2.5. These findings gain new insights in 
the pregnancy exposome and in the role of 
lipid mediators. Because metabolic profiles 
are more closely related to the phenotype 
compared with transcriptomic and proteomic 
profiles (Patti et al. 2012), these findings of 
PM-associated alterations of oxylipin profiles 
might have implications in later-life devel-
opment of air pollution associated diseases. 
However, the consequences of alterations 
in early-life oxylipin profiles for later life 
diseases must be further elucidated in further 
 prospective evaluations.
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